Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer
Henry Ford Health System
Summary
This is a pilot study to improve rates of germline genetic testing for black patients with aggressive prostate cancer as recommended by the updated guidelines by the National Cancer Comprehensive Network (NCCN) in 2018. In this study, consented patients will undergo a low-risk intervention of an educational session with a trained staff member on germline testing in prostate cancer and, if agreeable, subsequent germline cancer genetic testing via a commercial lab test.
Description
This is a prospective, single-arm, quality improvement initiative for the use of a standardized educational intervention on germline testing in black patients with prostate cancer to improve the rates of germline genetic testing among those recommended for testing. Patients who consent to the study will undergo a one-on-one in-person education session regarding the rationale and the benefits/risks of germline testing. The educational intervention will occur with a clinical research coordinator who will be trained to educate on germline testing in prostate cancer. At the start of the session,…
Eligibility
- Age range
- 18+ years
- Sex
- Male
- Healthy volunteers
- No
Inclusion Criteria: 1. Men, age greater than or equal to 18 years of age. 2. Men who racially identify as black or multiracial including black 3. Diagnosis of prostate cancer of any histology. 4. Must meet NCCN guidelines for germline testing 1. Men with very low, low or intermediate risk prostate per NCCN guidelines with a positive family history or intraductal histology. Family history here is considered significant if the patient has: * a first degree relative with prostate cancer or more than one first/second degree relative with prostate cancer, or * ≥3 cancers on same s…
Interventions
- BehavioralEducational video
The educational intervention will occur with a clinical research coordinator who will be trained to educate on germline testing in prostate cancer.
Location
- Henry Ford Cancer PavilionDetroit, Michigan